Shefali Agarwal, Chief Medical Officer at Epizyme, Inc. (EPZM), sold 7,103 shares at $20.44 ($153K) on 2020-01-27, disclosed to the SEC on 2020-01-27.
Open-market sale of $153k EPZM by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.64 | 1,843 | $45K | 29.7% |
| 2 | $20.44 | 2,630 | $54K | 35.2% |
| 3 | $20.44 | 2,630 | $54K | 35.2% |
| Total | $21.53 avg | 7,103 | $153K | 100% |
| Filing → |
| EPZM | SELL | 2022-02-09 | $2K | — | Filing → |
| EPZM | SELL | 2022-02-04 | $4K | — | Filing → |
| EPZM | SELL | 2022-01-28 | $6K | — | Filing → |